|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
EP0705344B8
(en)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Adenovirus vectors for gene therapy
|
|
AU687117B2
(en)
|
1993-10-25 |
1998-02-19 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
|
WO1995013365A1
(en)
|
1993-11-09 |
1995-05-18 |
Targeted Genetics Corporation |
Generation of high titers of recombinant aav vectors
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
ATE386131T1
(de)
|
1994-04-13 |
2008-03-15 |
Univ Rockefeller |
Aav-vermittelte überbringung von dna in zellen des nervensystems
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
JP2000506375A
(ja)
|
1996-01-26 |
2000-05-30 |
エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ |
アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
|
|
AR020107A1
(es)
|
1998-07-09 |
2002-04-10 |
Boehringer Ingelheim Pharma |
Metodo para identificar una sustancia capaz de reducir o eliminar la actividad de la presenilinasa, las sustancias identificables con dicho metodo, el usode estas ultimas en la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y las composiciones farmaceuticas que
|
|
CA2333467A1
(en)
|
1998-07-16 |
2000-01-27 |
Incyte Pharmaceuticals, Inc. |
Human presenilin-associated protein
|
|
US6979537B2
(en)
|
2000-01-10 |
2005-12-27 |
Scios, Inc. |
Methods for identifying inhibitors of neuronal degeneration
|
|
US6686449B2
(en)
|
2000-06-30 |
2004-02-03 |
Pharmacia & Upjohn Company |
Mutant presenilin 1 polypeptides
|
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
US7271313B2
(en)
|
2003-04-09 |
2007-09-18 |
The Brigham And Women's Hospital, Inc. |
Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss
|
|
CA2528963A1
(en)
|
2003-06-27 |
2005-01-13 |
Sirna Therapeutics, Inc. |
Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
|
|
WO2005037226A2
(en)
|
2003-10-17 |
2005-04-28 |
Georgia Tech Research Corporation |
Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders
|
|
PT1675956E
(pt)
|
2003-10-21 |
2010-11-04 |
Merck Serono Sa |
Sequência mínima de adn que actua como um isolador de cromatina e sua utilização na expressão de proteína
|
|
WO2005096781A2
(en)
|
2004-04-06 |
2005-10-20 |
University Of Massachusetts |
Methods and compositions for treating gain-of-function disorders using rna interference
|
|
JP5697297B2
(ja)
|
2004-05-14 |
2015-04-08 |
ロゼッタ ジノミクス リミテッド |
マイクロｎａｓおよびその使用
|
|
WO2005116250A2
(en)
|
2004-05-26 |
2005-12-08 |
Rosetta Genomics Ltd. |
Viral and viral associated mirnas and uses thereof
|
|
US8129334B2
(en)
|
2006-03-31 |
2012-03-06 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
WO2009042727A1
(en)
|
2007-09-24 |
2009-04-02 |
The Johns Hopkins University |
Immediate early gene arc interacts with endocytic machinery and regulates the trafficking and function of presenilin
|
|
KR20120089743A
(ko)
|
2009-11-09 |
2012-08-13 |
제네포드 테라퓨틱스 에이비 |
생체 내에서 최적화된 뉴런 특이적 연속 도파 합성을 위한 신규한 바이러스 벡터 구성물
|
|
US8853377B2
(en)
|
2010-11-30 |
2014-10-07 |
Shire Human Genetic Therapies, Inc. |
mRNA for use in treatment of human genetic diseases
|
|
CN103816540B
(zh)
|
2012-11-16 |
2018-01-02 |
中国科学院上海生命科学研究院 |
降低β‑抑制蛋白1与APH‑1蛋白的结合的物质在制备防治神经退行性疾病药物中的应用
|
|
CN115120746A
(zh)
|
2013-05-15 |
2022-09-30 |
明尼苏达大学董事会 |
腺相关病毒介导的基因向中枢神经系统转移
|
|
HK1222673A1
(zh)
|
2013-07-12 |
2017-07-07 |
The Children's Hospital Of Philadelphia |
Aav载体和用於抗aav(腺相关病毒)中和抗体的检测
|
|
GB201404470D0
(en)
*
|
2014-03-13 |
2014-04-30 |
Ucl Business Plc |
Therapeutic methods and materials
|
|
GB201413665D0
(en)
|
2014-07-03 |
2014-09-17 |
Transimmune Ag And Yale University |
Method for obtaining globally activated monocytes
|
|
WO2016118780A1
(en)
*
|
2015-01-21 |
2016-07-28 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
WO2016154055A1
(en)
|
2015-03-20 |
2016-09-29 |
Bluebird Bio, Inc. |
Vector formulations
|
|
WO2016209654A1
(en)
|
2015-06-22 |
2016-12-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for imaging and/or optogenetic control of light-responsive neurons
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
CN117018228A
(zh)
|
2016-05-27 |
2023-11-10 |
创思瑞普泰克斯公司 |
用合成信使rna治疗原发性纤毛运动障碍
|
|
WO2018045022A1
(en)
|
2016-08-30 |
2018-03-08 |
University Of South Florida |
Adipose derived stem cell exosomes and uses thereof
|
|
EP3573627A4
(en)
*
|
2017-01-24 |
2020-11-25 |
Fred Hutchinson Cancer Research Center |
SYSTEMS AND METHODS FOR EXPANSION OF HEMATOPOIETIC CELLS USING HYDROGELS
|
|
US11713470B2
(en)
|
2017-03-20 |
2023-08-01 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Targeted gene therapies for pain and other neuro-related disorders
|
|
ES3039647T3
(en)
|
2017-05-31 |
2025-10-23 |
Arcturus Therapeutics Inc |
Synthesis and structure of high potency rna therapeutics
|
|
EP3808849A1
(en)
|
2017-08-03 |
2021-04-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
CA3100946A1
(en)
|
2018-05-22 |
2019-11-28 |
The Brigham And Women's Hospital, Inc. |
Gene therapy for alzheimer's disease
|
|
BR112022010373A2
(pt)
|
2019-11-29 |
2022-08-16 |
Paros Bio Inc |
Terapia genética para doenças neurodegenerativas
|
|
JP2023512079A
(ja)
|
2020-01-31 |
2023-03-23 |
パロス バイオ インコーポレイテッド |
ポリヌクレオチドサイレンシング及び置換を使用する神経変性障害のための遺伝子療法
|